23andMe Research

Thanks in part to @23andMe research participants, @IMBatUQ demonstrated that women with a high genetic risk of developing depression are more likely to develop heart disease. imb.uq.edu.au/article/2024/1…

New landmark study led by @EdinburghUni and @KingsCollegeLon looking at genomes of 5M+ people across 29 countries — including 23andMe customers who consented to participate in research — uncovered ~300 previously unknown genetic links to depression. 23and.me/DepressionGene……

We are excited about the many positive conversations we had at the JP Morgan meeting this year, on the heels of our Discover23 press release. Looking forward to many more research collabs! investors.23andme.com/news-releases/…

How can you power drug development with evidence from the world’s largest recontactable genetics community? Find out here! 23andme.com/partner/

We are hiring for a postdoc to work on the genetics of autism. Come join our team! 23andme.com/careers/jobs/7…

Our blog post on the same work, for the lay reader. blog.23andme.com/articles/genet…

📌Publication alert: In a preprint from the @23andMeResearch team, we conducted one of the largest GWAS study of Long COVID and identified genetic links of chronic conditions with Long COVID. medrxiv.org/content/10.110…

Today we’re announcing a new study to advance research on lung cancer. While lung cancer research and targeted therapies have provided hope and progress for many, this study aims to learn more about the genetics behind the disease and its causes. More: 23and.me/3YjhWdH

A blog post on how our data can provide an edge for drug development blog.23andme.com/articles/a-new…

Excited about our latest paper in Blood Advances. Blog post here: blog.23andme.com/articles/new-g…

We're looking for a scientific lead for our long standing (15 years!) Parkinson's disease research program. The program includes over 35k genotyped, consented individuals with PD. If you have a passion for PD and people living with PD, check it out: 23andme.com/careers/jobs/7…

In a preprint from the @23andMeResearch team, we used Mendelian randomization to explore the genetically-predicted causal effects of Lp(a) on a range (n=489) of human traits and diseases. medrxiv.org/content/10.110…

In the latest edition of "Huh, I didn't expect that to work", our latest paper shows that LLMs can outperform existing methods for identifying causal genes in genome-wide association studies. 🧵 medrxiv.org/content/10.110…

Study in @NatureMedicine shows having 2 copies of APOE4 may cause Alzheimer's, not just increase risk. This shows the value of genetic testing. Early diagnosis = early treatment. Knowledge is power! Read more: 23and.me/3UUNy7q #AlzheimersResearch #GeneticTesting #23andMe

UPDATE: 23andMe to present preliminary efficacy & biomarker data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. More info here: 23and.me/ASCO24 #ASCO2024 #CancerResearch

Today at #AACR24, our own Kim Gerrick is presenting at 3:20PM PST in Room 30, hope to see you there!

We're looking for a Sr. Bioinformatics Scientist to join our Research team! More details here: 23and.me/4aqlFJP

We're heading to San Diego for the American Association for Cancer Research Annual Meeting to connect and share updates from the @23andMe Therapeutics team. Hope to see you there! More details: 23and.me/4aksIDV #AACR24

In honor of #PSCAwarenessDay, learn more about primary sclerosing cholangitis, a rare disease where the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked. 23andme.com/rare-disease-r…